These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 71663)

  • 41. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Brod SA; al-Sabbagh A; Sobel RA; Hafler DA; Weiner HL
    Ann Neurol; 1991 Jun; 29(6):615-22. PubMed ID: 1716432
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Involvement of distinct murine T-cell receptors in the autoimmune encephalitogenic response to nested epitopes of myelin basic protein.
    Sakai K; Sinha AA; Mitchell DJ; Zamvil SS; Rothbard JB; McDevitt HO; Steinman L
    Proc Natl Acad Sci U S A; 1988 Nov; 85(22):8608-12. PubMed ID: 2460872
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Natural occurrence of thymocytes that react with myelin basic protein.
    Steinman L; Cohen I; Teitelbaum D
    Neurology; 1980 Jul; 30(7 Pt 1):755-9. PubMed ID: 6156429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Direct cell-mediated cytotoxicity in experimental allergic encephalomyelitis.
    Eggers AE; Hibbard CA
    J Neurol Sci; 1981 Jan; 49(1):109-16. PubMed ID: 6162919
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MHC class II isotype- and allele-specific attenuation of experimental autoimmune encephalomyelitis.
    de Graaf KL; Barth S; Herrmann MM; Storch MK; Otto C; Olsson T; Melms A; Jung G; Wiesmüller KH; Weissert R
    J Immunol; 2004 Aug; 173(4):2792-802. PubMed ID: 15294998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Antigen, host and adjuvant requirements for induction of hyperacute experimental autoimmune encephalomyelitis.
    Lennon VA; Westall FC; Thompson M; Ward E
    Eur J Immunol; 1976 Nov; 6(11):805-10. PubMed ID: 63374
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Definition of encephalitogenic and immunodominant epitopes of guinea pig myelin basic protein (Gp-BP) in Lewis rats tolerized neonatally with Gp-BP or Gp-BP peptides.
    Vandenbark AA; Vainiene M; Celnik B; Hashim GA; Buenafe A; Offner H
    J Immunol; 1994 Jul; 153(2):852-61. PubMed ID: 7517426
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis.
    Aharoni R; Teitelbaum D; Sela M; Arnon R
    Proc Natl Acad Sci U S A; 1997 Sep; 94(20):10821-6. PubMed ID: 9380718
    [TBL] [Abstract][Full Text] [Related]  

  • 49. LF 15-0195 inhibits the development of rat central nervous system autoimmunity by inducing long-lasting tolerance in autoreactive CD4 T cells.
    Duplan V; Dutartre P; Mars LT; Liblau RS; Druet P; Saoudi A
    J Immunol; 2003 Feb; 170(4):2179-85. PubMed ID: 12574391
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies on autoimmune encephalomyelitis in the guinea pig--III. A comparative study of two autoantigens of central nervous system myelin.
    Lebar R; Vincent C; Fischer-le Boubennec E
    J Neurochem; 1979 May; 32(5):1451-60. PubMed ID: 438816
    [No Abstract]   [Full Text] [Related]  

  • 51. A fusion protein consisting of IL-16 and the encephalitogenic peptide of myelin basic protein constitutes an antigen-specific tolerogenic vaccine that inhibits experimental autoimmune encephalomyelitis.
    Mannie MD; Abbott DJ
    J Immunol; 2007 Aug; 179(3):1458-65. PubMed ID: 17641011
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Antigen-specific therapy of experimental allergic encephalomyelitis by soluble class II major histocompatibility complex-peptide complexes.
    Sharma SD; Nag B; Su XM; Green D; Spack E; Clark BR; Sriram S
    Proc Natl Acad Sci U S A; 1991 Dec; 88(24):11465-9. PubMed ID: 1722335
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Treatment of autoimmune diseases by oral tolerance to autoantigens.
    Weiner HL; Miller A; Khoury SJ; Zhang ZJ; al-Sabbagh A; Brod SA; Lider O; Higgins P; Sobel R; Matsui M
    Adv Exp Med Biol; 1995; 371B():1217-23. PubMed ID: 7502787
    [No Abstract]   [Full Text] [Related]  

  • 54. Absence of "original antigenic sin" in autoimmunity provides an unforeseen platform for immune therapy.
    Steinman L
    J Exp Med; 1999 Apr; 189(7):1021-4. PubMed ID: 10190892
    [No Abstract]   [Full Text] [Related]  

  • 55. Autoimmune reactions against myelin basic protein induced by corona and measles viruses.
    ter Meulen V
    Ann N Y Acad Sci; 1988; 540(1):202-9. PubMed ID: 2462802
    [No Abstract]   [Full Text] [Related]  

  • 56. Autoimmune demyelination in the central nervous system.
    Tabira T
    Ann N Y Acad Sci; 1988; 540():187-201. PubMed ID: 2462801
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
    Vanderlugt CL; Neville KL; Nikcevich KM; Eagar TN; Bluestone JA; Miller SD
    J Immunol; 2000 Jan; 164(2):670-8. PubMed ID: 10623809
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of the rat and mouse encephalitogenic determinants.
    Burgess KT; Bernard CC; Carnegie PR
    Adv Exp Med Biol; 1978; 100():303-5. PubMed ID: 80943
    [No Abstract]   [Full Text] [Related]  

  • 59. Induction of resistance to experimental allergic encephalomyelitis in newborn guinea pigs.
    Staykova M; Kozovska M; Kirazjan N; Goranov I
    Neurol Psychiatr (Bucur); 1989; 27(3):225-9. PubMed ID: 2479972
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The encephalitogenic activity and myelin basic protein content of isolated oligodendroglia.
    McDermott JR; Iqbal K; Wisniewski HM
    J Neurochem; 1977 May; 28(5):1081-8. PubMed ID: 68098
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.